Phase I/II study is tracking to meet primary endpoints RECCE ® 327 at 3,000mg over 15 minutes marks the fastest infusion rate of a high concentration Cohort fully recruited with remaining subjects to ...

Independent Safety Committee approves the next cohort dosing of RECCE ® 327 (R327) at a faster infusion rate of 15 minutes of 3,000mg via intravenous (IV) administration R327 was shown to be safe and ...

NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Today, EMED Technologies, a global leader in drug delivery and infusion therapy innovation, today announced the issuance of U.S. Patent No. 12,403,243 that ...

A calculation error related to the Rule of 6 may have contributed to an infant's death recently when it led to a misplaced decimal point and the preparation of a ...

Privigen (human immunoglobulin G) is a prescription drug used to treat certain immune system conditions. The drug comes as an intravenous (IV) infusion (an injection into a vein given over time).

Dec. 3 (UPI) --Privately owned, standalone infusion centers are increasingly providing a comfortable and convenient alternative to hospitals and doctors' offices for people on prescribed medications ...